A clinical pathway for older prostate cancer patients
- Conditions
- malignancy of the prostateProstate cancer10038597
- Registration Number
- NL-OMON40972
- Lead Sponsor
- IVE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
• Diagnosis of prostate cancer
• Age at least 65 and at least one chronic disease (of a list of 30 diseases of the RIVM);Specific criteria for the different treatment options:
After radical prostatectomy inclusion 1 year after operation if:
• PSA < 0,1
• No other active treatment by urologist (for example erectile dysfunction or incontinence)
After radiotherapy (in- or external) inclusion 1 year after radiotherapy if:
• PSA declining
• No other active treatment by urologist (for example erectile dysfunction or incontinence)
Watchful waiting inclusion 6 months after start watchful waiting if:
• PSA stable
• No other active treatment by urologist (for example erectile dysfunction or incontinence)
Hormone therapy inclusion 6 months after start hormone therapy if:
• Health complaints absent or stable
- In active medical treatment
- After-care by GP not medically safe
- in the normal situation the patient would be checked by the urologist for at least one year
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome measure of this project is the existence of a succesful<br /><br>clinical pathway for older prostate cancer patients. This will be assessed by<br /><br>the following criteria:<br /><br><br /><br>- GPs do not refer patients to the urologist (unless for recurrence/metastasis).<br /><br>- The majority of the patients is satisfied<br /><br>- The participating GPs and urologists are convinced and confident</p><br>
- Secondary Outcome Measures
Name Time Method <p>perceived quality of care and prostate cancer specific quality of life, health<br /><br>care use and satisfaction with videoconsultations</p><br>